July 14, 2020 Pilot Scheme On Facilitation For Persons Participating In Arbitral Proceedings In Hong Kong.
July 10, 2020 Ocumension Therapeutics HK$1.55 Billion (US$200.4 Million) Initial Public Offering On The Hong Kong Stock Exchange.
July 9, 2020 Hong Kong – Davis Polk Advises Shenzhen Hepalink Pharmaceutical Group Co., Ltd. On Its HK$4.05 Billion ($523 Million) Initial Public Offering.